Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Cash & Equivalents: 2009-2020

Historic Cash & Equivalents for Neurocrine Biosciences (NBIX) over the last 12 years, with Dec 2020 value amounting to $190.3 million.

  • Neurocrine Biosciences' Cash & Equivalents fell 26.85% to $311.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $311.1 million, marking a year-over-year decrease of 26.85%. This contributed to the annual value of $190.3 million for FY2020, which is 69.46% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Cash & Equivalents of $190.3 million as of FY2020, which was up 69.46% from $112.3 million recorded in FY2019.
  • Neurocrine Biosciences' Cash & Equivalents' 5-year high stood at $254.7 million during FY2017, with a 5-year trough of $83.3 million in FY2016.
  • For the 3-year period, Neurocrine Biosciences' Cash & Equivalents averaged around $148.1 million, with its median value being $141.7 million (2018).
  • In the last 5 years, Neurocrine Biosciences' Cash & Equivalents surged by 205.90% in 2017 and then tumbled by 44.36% in 2018.
  • Yearly analysis of 5 years shows Neurocrine Biosciences' Cash & Equivalents stood at $83.3 million in 2016, then skyrocketed by 205.90% to $254.7 million in 2017, then slumped by 44.36% to $141.7 million in 2018, then fell by 20.76% to $112.3 million in 2019, then surged by 69.46% to $190.3 million in 2020.